All posts by Satish Medicetty
Dr. Medicetty is GTCbio’s President and has a great vision to create impactful platforms that bring together right people to drive the future of science and medicine. He is a biotech entrepreneur and his background includes a unique blend of executive management, business development and scientific expertise. He received a degree (BVSc – equivalent to DVM) in Veterinary Medicine from A.N.G.R.A.University, India. He received a PhD from Kansas State University, Manhattan, KS. Later, he received his MBA from Weatherhead School of Management, CWRU, Cleveland, OH.
This continues to be an interesting question, and I approached it with a different perspective from a recent experience. I just got back from the Society for Neuroscience (SFN) 49th Annual Meeting, which had almost 30,000 attendees. I have been at this meeting many times in the past and yet I am surprised by the…read more
Enzymes have historically been considered attractive drug targets for therapeutics because of their specificity and susceptibility to drug modulation. More than 250 genes coding for enzymes, have been identified as FDA-approved drug targets and this further highlights the continued importance of investigating enzyme targets. Therefore, with the rise in demand for effective therapeutic agents, the…read more